Andere talen Agile Therapeutics, Inc.

Aandelen

AGRX

US00847L3087

Beurs gesloten - OTC Markets Andere beurzen 20:00:26 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,4 ^USD	-0,07%		+8,11%	-79,49%

28/03	Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024
28/03	Agile Therapeutics, Inc. Rapporteert winstresultaten voor het vierde kwartaal en het volledige jaar eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Agile Therapeutics: Q4 Earnings Snapshot	28/03
Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M	28/03
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update	28/03
Agile Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/03
Agile Therapeutics, Inc.(OTCPK:AGRX) dropped from S&P TMI Index	28/03
Agile Therapeutics Announces Delisting from Nasdaq	25/03
Agile Therapeutics, Inc.(OTCPK:AGRX) dropped from NASDAQ Composite Index	25/03
North American Morning Briefing : Stocks Struggle After New Records	22/03
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024	21/03
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024	20/03
North American Morning Briefing : Stock Futures -2-	19/03
Agile Therapeutics Inc. Completes Pay-Off the Remainder of its Debt Facility	14/03
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution	13/03
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds	22/02
Top Premarket Gainers	22/02
Agile Therapeutics, Inc. Announces Senior Secured Term Loan Credit Facility of Up to $35.0 Million	15/02
Agile Therapeutics, Inc. Provides Revenue Guidance for the Full Year Ended December 31, 2023	15/02
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update	15/02
AGILE THERAPEUTICS - THE BIDEN-HARRIS ADMINISTRATION ANNOUNCES NEW GUIDANCE TO ENABLE EXPANDED ACCESS TO ALL FDA-APPROVED CONTRACEPTIVES WITHOUT COST	24/01
The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost	23/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Agile Therapeutics, Inc.

Aandelen

AGRX

US00847L3087

Andere talen

Filters